Weekly progress on share repurchase program to cover share plans and reduce capital Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), April 7, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 9, 2026 its intention to repurchase ordinary shares with an aggregate market value of €500 million and reduce its issued capital. On March 12, 2026, the company commenced repurchasing ordinary shares for a total amount of €540 million, of which €40 million to cov...
JDE Peet’s transfers shares to participants under its employee incentive plans PRESS RELEASE Amsterdam, April 2, 2026 This is a press release by JDE Peet’s N.V. (JDE Peet’s or the Company) pursuant to the provisions of section 13, paragraph 1 and section 17, paragraph 3, of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) in connection with the recommended public offer by Keurig Dr Pepper, Inc. (the Offeror) for all the issued and outstanding shares in the capital of JDE Peet’s (the Offer). This press release does not constitute an offer, or any solicitation of an...
The tariff war between US and China has eased, but with the Iran conflict and an erratic Trump, uncertainty will continues unabated. Energy prices have gone ballistic, with gas prices doubling in Europe and has hit the cyclical stocks hard. KBC macro-econimists have hiked the inflation expectation for 2026 from 1.9% to 3.3%. While the macro-economic impact has been limited so far, a prolonged uncertain situation will result in economic damage. We continue our defensive stance in our Benelux Dyna...
Keurig Dr Pepper Acquires JDE Peet’s and Announces Rafael Oliveira as CEO of Future Global Coffee Co. Transaction creates global coffee powerhouseOliveira will continue as JDE Peet’s CEO and joins KDP to lead combined coffee business This is a joint press release by Keurig Dr Pepper Inc., Kodiak BidCo B.V. and JDE Peet’s N.V. in connection with the recommended public cash offer by Kodiak BidCo B.V. (the “Offeror”) for all issued and outstanding ordinary shares in the capital of JDE Peet’s N.V. (such offer, the “Offer”, such shares, the “Shares” and each holder of such Shares, a “Sharehol...
Corbion published agenda for AGM Corbion has published its agenda for the upcoming Annual General Meeting of Shareholders (AGM) to be held on 13 May 2026. The full AGM agenda together with explanatory notes is available on Corbion's under Investor relations --> Shareholder information --> Shareholder meetings. Attachment
UCB announced that the European Commission approved Kygevvi (doxecitine and doxribtimine) under exceptional circumstances as the first and only treatment for paediatric and adult patients with genetically confirmed thymidine kinase 2 deficiency (TK2d) with an age of symptom onset on or before 12 years. The approval comes after the positive CHMP opinion announced in February 2026. Beyond the EU, the product received FDA approval in the US in 4Q25. € 284 TP and BUY maintained.
CTP: Asian financings. KPN: Increases internet prices and discontinues 100Mbit/s fiber optic subscription. Magnum Ice Cream Company: Closing the acquisition of Kwality Wall's in India. SBM Offshore: Mopane 2028? Staffing Sector: Belgium staffing February Temp volume decline moderating on easier comps; stable underlying but blue collar softer. Unilever plc: Morris dancing reaches its climax. Universal Music Group: €500m buyback welcome, management stresses dislocated valuation. WDP:...
Weekly progress on share repurchase program to cover share plans and reduce capital Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), March 31, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 9, 2026 its intention to repurchase ordinary shares with an aggregate market value of €500 million and reduce its issued capital. On March 12, 2026, the company commenced repurchasing ordinary shares for a total amount of €540 million, of which €40 million to co...
Since our 12-month target price upgrade to €18.60 and change in recommendation from Sell to HOLD on 17 November 2025, Corbion has delivered its Capital Markets Day and full year results. Corbion confirmed at its 2025 results that the company had taken advantage of the low sugar price to hedge all its exposure for 2026 and 75% for 2027. This extends the Goldilocks scenario of lower costs and higher revenues from 2026 into 2027 and supports approximately half of the company's guided adj. EBITDA ma...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.